Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
529.74
468.31
394.41
420.69
387.04
282.95
264.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
529.74
468.31
394.41
420.69
387.04
282.95
264.59
Raw Material Cost
296.86
280.77
238.66
269.16
236.72
175.07
140.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
70.41
93.13
73.92
69.17
44.16
34.27
31.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.61
0.60
0.23
0.34
0.35
0.22
0.22
Selling and Distribution Expenses
52.45
40.72
32.98
29.51
30.54
24.85
41.60
Other Expenses
-3.59
-6.83
-5.58
-5.41
-3.26
-2.37
-2.26
Total Expenditure (Excl Depreciation)
384.40
346.90
289.95
314.13
279.14
210.70
191.33
Operating Profit (PBDIT) excl Other Income
145.29999999999998
121.4
104.5
106.6
107.89999999999999
72.30000000000001
73.3
Other Income
13.02
25.68
20.00
19.52
3.52
2.86
8.69
Operating Profit (PBDIT)
179.35
159.37
136.00
140.85
123.11
85.33
90.35
Interest
0.61
0.60
0.23
0.34
0.35
0.22
0.22
Exceptional Items
1.76
0.00
0.00
-0.74
0.51
0.09
-0.24
Gross Profit (PBDT)
232.88
187.55
155.75
151.52
150.31
107.88
123.80
Depreciation
23.74
16.98
15.10
15.98
14.74
11.63
9.78
Profit Before Tax
156.76
141.79
120.68
123.78
108.52
73.57
80.11
Tax
20.88
19.23
16.01
16.19
14.52
10.75
11.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
135.88
122.56
104.67
107.59
94.00
62.83
68.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
135.88
122.56
104.67
107.59
94.00
62.83
68.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
135.88
122.56
104.67
107.59
94.00
62.83
68.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,493.76
1,344.15
1,249.33
469.03
361.29
278.96
266.41
Earnings per share (EPS)
0.89
0.82
0.7
0.72
0.63
0.42
0.46
Diluted Earnings per share
0.89
0.82
0.7
0.72
0.63
0.42
0.46
Operating Profit Margin (Excl OI)
26.92%
24.92%
25.58%
25.04%
27.09%
25.04%
27.17%
Gross Profit Margin
34.07%
33.9%
34.42%
33.22%
31.85%
30.11%
33.97%
PAT Margin
25.65%
26.17%
26.54%
25.57%
24.29%
22.2%
26.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 24.38% vs 15.26% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 200.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Zhejiang Haisen Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
529.74
0
529.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
529.74
0
529.74
Raw Material Cost
296.86
0
296.86
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
70.41
0
70.41
Power Cost
0
0
0.00
Manufacturing Expenses
0.61
0
0.61
Selling and Distribution Expenses
52.45
0
52.45
Other Expenses
-3.59
0.00
-3.59
Total Expenditure (Excl Depreciation)
384.40
0
384.40
Operating Profit (PBDIT) excl Other Income
145.34
0.00
145.34
Other Income
13.02
0
13.02
Operating Profit (PBDIT)
179.35
0
179.35
Interest
0.61
0
0.61
Exceptional Items
1.76
0
1.76
Gross Profit (PBDT)
232.88
0
232.88
Depreciation
23.74
0
23.74
Profit Before Tax
156.76
0
156.76
Tax
20.88
0
20.88
Provisions and contingencies
0
0
0.00
Profit After Tax
135.88
0
135.88
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
135.88
0
135.88
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
135.88
0
135.88
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,493.76
0
1,493.76
Earnings per share (EPS)
0.89
0
0.89
Diluted Earnings per share
0.89
0
0.89
Operating Profit Margin (Excl OI)
26.92%
0%
0.00
26.92%
Gross Profit Margin
34.07%
0%
0.00
34.07%
PAT Margin
25.65%
0%
0.00
25.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 52.97 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 13.59 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 24.38% vs 15.26% in Dec 2024
Annual - Interest
Interest 0.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 200.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.92%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
